Metabolic syndrome in México;El síndrome metabólico en México

Medicina Interna de Mexico

Volumn 24, Issue 4, 2008, Pages 251-261

  Madrigal, Jaime Carranza ^a,b   Correa, Sonia María López ^a  

^a UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

^b NONE   (Mexico)

Author keywords

Depression; Endothelial dysfunction; Insulin resistance; Metabolic syndrome

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD VESSEL INJURY; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; DEPRESSION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; FEMALE; GLUCOSE METABOLISM; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METABOLIC SYNDROME X; MOOD CHANGE; OBESITY;

EID: 50249084377     PISSN: 01864866     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Grundi SM, Cleeman JI, Daniela SR, Donato KA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005;112(17):2735-52.
2. Aguilar-Salinas C, Rojas B, Gómez-Pérez FJ, Valles V, et al. Analysis of the agreement between World Health Organization criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome: results from a population-based study. Diabetes Care 2003;26(5):1653.
3. Diamant M, Tushuizen ME. The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD. Curr Diab Rep 2006;6(4):279-86.
4. Mancia G, De Backer G, Dominiczak A, Cifkova R, et al. 2007 Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). Eur Heart J 2007;28(12):1462-536.
5. Fernández BC, Alvarado RR, Guerrero MFJ. Síndrome metabólico. Diagnóstico, epidemiología y riesgo cardiovascular. En: Esper R. Aterotrombosis en el tercer milenio. Pautas terapéuticas. Barcelona: Prous Science 2004;pp:85-109.
6. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001;86(11):5457-64.
7. Bonora E, Formentini G, Calcaterra F, Lombardi S, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002;25(7):1135-41.
8. Correti MC, Anderson TJ, Benjamin EJ, Celermajer D, et al. Guidelines for ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39(2):257-65.
9. Neunteufl T, Heher S, Katzenchlager R, Wolf G, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000;86(2):207-10.
10. Al-Shali K, House AA, Hanley AJ, Khan HM, et al. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis 2005;178(2):319-25.
11. Hegele RA, Al-Shali K, Khan HM, Hanley AJG, et al. Carotid ultrasound in one, two and three dimension. Vasc Dis Prevention 2005;2:87-92.
12. Bech P. Rating scales for mood disorders: applicability, consistency and construct validity. Acta Psychiatr Scand 1988;78(Suppl 345):45-55.
13. Conde V, Useros E. Adaptación castellana de la escala de evaluación conductual para la depresión de Beck. Rev Psiquiatr Psicol Med Eur Am 1975;12:217-36.
14. Conde LV, Franch VJI. Escalas de evaluación comportamental para la cuantificación de la sintomatología psicopatológica en los trastornos angustiosos y depresivos. Valladolid: Departamento de psicología médica y de psiquiatría del Hospital Clínico de la Facultad de Medicina, 1984.
15. O'Brien E, Beevers G, Lip GY. ABC of hypertension: Blood pressure measurement. Part IV-automated sphygmomanometry: self blood pressure measurement. BMJ 2001;322(7295):1167-70.
16. Tapia-Conyer R, Sarti E, Kuri P, Ruiz-Matus C y col. Metodología epidemiológica, En: Tapia CR (editor). El manual de salud pública. México: Intersistemas, 2006;pp:1-57.
17. Córdoba JA, Barquera S, Campos I, Hernández M, et al. Análisis de conglomerados de factores de riesgo para enfermedades crónicas en adultos mexicanos. Draft, 2007.
18. Coca A, Aranda P, Bertomeu V, Bonet A, et al. Estrategias para un control eficaz de la hipertensión arterial en España. Documento de Consenso. Hipertensión 2006;23(05):152-6.
19. Bello M, Puentes-Rosas E, Medina-Mora ME, Lozano R. Prevalencia y diagnóstico de depresión en población adulta en México. Salud Publica Méx 2005;4(Supl 1):S4-S11.
20. Herva A, Rasanen P, Miettunen J, Timonen M, et al. Co-ocurrence of metabolic syndrome with depression an anxiety in young adults: the Northern Finland 1966 Birth Cohort Study. Psychosom Med 2006;68(2):213-6.
21. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: Does cortisol play a role? Biol Psychiatry 2004;55(1):1-9.
22. Franco SO, Rosendo BN, Carranza MJ. Utilidad de los criterios del síndrome metabólico del NCEP y de la Federación Internacional de Diabetes (FID) para detectar resistencia a la insulina. Med Int Mex 2006;235.